AzTrials
AzTrials

OsteoporosisGAPNCT04787679

Image-guided Computational and Experimental Analyses of Fractured Patient's Bone (GAP)

An observational study of Osteoporosis and Fragility Fracture, run by Laura Maria Vergani at 1 site in Italy.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Due to the increase in the average age of the population, the projections on the number of age-dependent bone fractures appear to be constantly increasing. They are mainly due to bone pathologies, including osteoporosis. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Osteoporosis, Fragility Fracture
What is being tested?
Hip replacement surgery
Type of treatment
Surgery or procedure
How many people
52 participants
Where
1 siteItaly
Study dates
9 Nov 2020to 9 Aug 2028
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: The population consists of 52 subjects, 26 of whom are prosthetic and have osteoporosis detectable by preoperative computed tomography (CT) scan and 26 prosthetic whose CT scan does not indicate the presence of osteoporosis. The classification of the two groups will be made exclusively by analysis of routine preoperative CT scans according to standard radiological classification.

Who may be able to join

  • Age: >=18 years
  • primary hip replacement
  • Signature of informed consent
  • Patients who have a routine preoperative CT scan

Who cannot join

  • Patients unrelated to the inclusion criteria of this study
  • Bone disease (non-osteoporotic) such as to invalidate sample analysis, including but not limited to genetic disorders and bone tumors
  • Patients with contralateral hip replacement and/or other synthetic means in the contralateral hip
  • Patients with synthesis devices in the hip of interest

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Federica Buccino contact

federica.buccino@polimi.it

Italy1 site, 1 recruiting
  • IRCCS Istituto Ortopedico Galeazzi

    Miano, Milano, 20161

    Elena M Cittera, 0266214057, elena.cittera@grupposandonato.it

    Sara Zacchetti, 0266214048, sara.zacchetti@grupposandonato.it

    Recruiting

Other trials in Italy

About this study

Due to the increase in the average age of the population, the projections on the number of age-dependent bone fractures appear to be constantly increasing.

They are mainly due to bone pathologies, including osteoporosis. The latter leads to a reduction in bone mineral density and deterioration of the micro-architecture, with a consequent increase in bone fragility. However, the mechanisms of damage at the micro-scale have not yet been elucidated and there is no universally recognized damage criterion. Recent research has evaluated the importance of implementing computational models to study the influence of bone gaps, canaliculi and microporosities on the propagation of damage. These models need to be validated through experimental tests, still lacking, in particular on human bones, in the current scientific landscape. Once the experimental validation of computational models has been developed, it will be possible to introduce new fracture indices at the micro-scale, useful for a preventive diagnosis of osteoporosis.

Read the detailed description

The study of the mechanisms of bone damage, which occur at the multiscale, is of fundamental importance for the understanding of fracture processes. In particular, age-related fractures are continuously increasing due to the increase in average age and widespread diseases such as osteoporosis. They result in high economic burdens, morbidity (including psychological, e.g., frailty), and increased mortality. In order to reduce the impact of bone fractures on health and economy, early diagnosis is the key. In this context, one must consider that bone is characterized by a complex hierarchical structure. Both the cortical and trabecular sections consist of micrometric lamellae, composed of collagen fibrils, within which osteocytes are found. They reside in sub-micrometer cavities called lacunae, which are connected by a dense network of canaliculi. At the nanoscale, the fibrils consist primarily of collagen and hydroxyapatite crystals. This complex architecture is reflected in fracture patterns: damage, in fact, occurs at the multiscale. However, fracture patterns and their associated physical phenomena are still not understood, especially at the microscale.

Recently, microscale imaging techniques have been combined with subject-specific numerical models, which are able to calculate local values of bone stress and strain. Preliminary studies have focused on evaluating a possible interaction between micro-cracks and microstructural porosity. This particular research focuses on the lacunar network, which is presumed to significantly affect bone resistance to fracture although the actual role of the lacunar network is not yet elucidated. First, lacunae are areas of stress concentration, which apparently lead to weakening of the bone structure. However, in most cases, the lacunae make a positive contribution to toughness by deflecting the crack front. The connection between the lacunae, determined by the network of canaliculi, is also reduced in osteoporotic subjects, preventing the slowing of damage. In this sense, bone can be considered a damage tolerant material. Donaldson et al developed computational models and estimated a threshold for microdamage initiation and propagation. They used computerized micro-tomography of murine femurs and evaluated the influence of different algorithms on the propagation of in-silico damage. Further results showed that the damage always occurs on the surfaces of blood vessels or porosities and does not instead start from the lacunae. However, further simulations and models would be needed to verify the effectiveness of the damage models.

Computational damage models also require experimental validation. Preliminary studies have been conducted in two main directions: in-vivo imaging and image-guided failure assessment (IGFA) techniques. The first approach allows nondestructive monitoring of bone damage in living animals. The second approach, implemented by A. Levchuk et al. (8), shows enormous potential by allowing the study of microcrack initiation and propagation with sub-micrometer resolution, but only on small animals.

The current research for the first time wants to perform tests on human bone samples applying IGFA techniques.

Despite several studies on the characterization of damage models at the micro-scale, a validation of computational models of fracture on human subjects is still lacking. In addition, the role of morphological features at the micro-scale in samples is still unknown.

These micro-scale studies could improve clinical understanding of bone fracture and prediction of fracture risk. Currently, clinicians use bone mineral density, which is a macro-scale parameter, as the most common predictor of bone fracture. However, recent studies demonstrate the importance of a thorough characterization of the geometric and morphologic characteristics of the microarchitecture.

OBJECTIVES

General Objective The study aims at the experimental validation of computational models of bone damage at the micro-scale. The general objective is pursued by controlled damage in a micro-compression machine on human bone samples from femoral head. The machinery is placed inside a synchrotron.

Primary Objective The primary objective of the present study is to evaluate the difference in the attraction of bone damage with respect to gaps in the two groups considered (osteoporotic and non-osteoporotic) following micro-compression testing.

The discriminating parameter chosen turns out to be the number of bone gaps encountered by micro-damage. We expect to observe an effect size of 0.4 between the two groups with respect to the chosen parameter.

Secondary Objectives

  • Determination of the role of gaps, canaliculi and other bone microstructures in damage. Human bone samples are scanned by micro-tomograph for the definition of microstructural morphological parameters and the realization and analysis of numerical models.
  • Validation of these numerical models of damage by micro-compression tests carried out in situ in a synchrotron of adequate resolution
  • Quantification of damage in human bone samples affected by osteoporosis
  • Definition of micro-scale fracture indices, useful for the early diagnosis of osteoporosis
Being tested
Hip replacement surgery
Keywords
lacunae, damage models, micro-cracks, synchrotron, numerical models
Medical subject headings
Osteoporosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hip replacement surgeryProcedure or surgery

    After hip replacement surgery the sponsor obtains femoral head samples for the study

Study groups in NCT04787679
Study groupRoleWhat they receive
Osteoporotic patientsOsteoporotic patients, age > 18 years old
Receives: Procedure: Hip replacement surgery
Non osteoporotic patientsNon osteoporotic patients, age > 18 years old
Receives: Procedure: Hip replacement surgery

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of lacunae interested by damage

    We expect to observe difference in osteoporotic and non osteoporotic samples interested or not by the damage

    Measured: six months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Mar 2021
  2. Study start9 Nov 2020
  3. Primary completion9 Jul 2026 (estimated)
  4. Study completion9 Aug 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Cross-sectional
Enrolment
52 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04787679
Sponsor's protocol ID
Polimi_Galeazzi_GAP
Acronym
GAP
Status last verified
Jan 2026
First submitted
1 Mar 2021
Last updated
29 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Zanre V, Nguyen D, Kochetkova T, Kusch-Wieser J, Gerina M, Silva BFB, Zysset P, Schwiedrzik J. A quantitative approach for high-throughput mapping of collagen fibril orientation using polarization-dependent Second Harmonic Generation. Acta Biomater. 2026 Jun;216:272-286. doi: 10.1016/j.actbio.2026.04.037. Epub 2026 Apr 23.

    PubMed 42034302

Questions about this trial

What is this clinical trial studying?

An observational study of Osteoporosis and Fragility Fracture, run by Laura Maria Vergani at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Laura M Vergani (+393393758630, luigi.zagra@fastwebnet.it), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of lacunae interested by damage (time frame: six months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04787679, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in